B
lymphocytes must integrate multiple biochemical signaling pathways to propagate humoral immune responses. Throughout this process, B cells are activated by a number of stimuli with overlapping and unique biochemical pathway activation potential. The unique contribution of individual receptors participating in B cell-mediated immune responses continues to be of great interest. CD40, a member of the tumor necrosis factor receptor family, plays a central role in humoral immunity (1) . CD40 activation of B cells results in the activation of numerous biochemical pathways, contributing to biological outcomes including enhanced cell survival and proliferation, germinal center formation, memory B cell development, and Ig isotype switching and affinity maturation (2) . Although we know the contribution of multiple biochemical signaling pathways to each of these processes, the mechanisms of CD40's unique contributions are still not clear.
CD40 ligation, in common with a number of B cell stimuli, activates the Rel͞NF-B transcription factors, which are major regulators of immune and inflammatory responses (3, 4) . Five members of this family exist in mammals: NF-B1 (encoding p105, which is constitutively processed to p50), NF-B2 (encoding p100, which is processed to p52), RelA (p65), c-Rel, and RelB. In unstimulated cells, inactive NF-B dimers reside in the cytoplasm through interaction with one of a family of inhibitory molecules, collectively termed inhibitors of B (IBs). Appearance in the nucleus of NF-B capable of DNA binding and transcription enhancement results from the activation of kinases that phosphorylate key serine residues on IBs, signaling their ubiquitination and degradation (5) . Recent work has shown two distinct pathways regulating phosphorylation of IB proteins, resulting in the release of specific and distinct Rel dimers. Type 1 involves activation of the IKK complex, which consists of two catalytic subunits (IKK␣ and IKK␤) and one regulatory subunit (IKK␥͞NEMO). Activation of the IKK complex results in the degradation of IB␣ and -␤, which release p50:RelA and p50:cRel dimers (6) (7) (8) (9) . Type 2 involves activation of NF-Binducing kinase, which associates with two IKK␣ molecules. Together, they recognize and bind to the C-terminal portion of p100 (also referred to as IB␦), resulting in p100 processing to p52 and preferential release of p52:RelB dimers (10, 11) . In recent years, the generation of gene knockout mice has helped to elucidate the contribution of Rel family members to a diverse set of cellular responses. Although these studies have revealed overlapping contributions of Rel proteins to processes such as proliferation and cell survival, they have also identified distinct biological roles of individual family members (12) (13) (14) (15) (16) . As such, differential activation of the type 1 and type 2 NF-B pathways has potentially important implications for receptor-mediated gene induction.
Previous work examined gene expression profiles in B cells activated by soluble CD40 ligand (sCD40L) and lipopolysaccharide (LPS) (17) . We found that the two stimuli activated similar sets of biochemical pathways but that each also activated a unique gene set. Recent studies defining the contribution of p52 and RelB have shed light on the tremendous contribution of the type 2 NF-B pathway to humoral immunity (15, 18) . This finding led to our speculation that the unique gene set induced by sCD40L, which included genes involved in adhesion, migration, lymphoid organization, and germinal center formation, could result from CD40L activation of the type 2 NF-B pathway, a property that LPS lacks.
In the present study, we analyzed the contribution of type 1 and type 2 NF-B activity to CD40-mediated responses in primary B cells. Through use of mice deficient in one or more Rel family member, we show that the type 1 and type 2 NF-B pathways differentially contribute to CD40-mediated B cell survival, proliferation, adhesion, and gene expression. We show that cellular responses common to CD40L and LPS treatment of B cells require their shared capacity to activate the type 1 NF-B pathway. In addition, we show that other B cell responses, unique to CD40, result from the receptor's ability to activate both arms of the NF-B pathway.
Materials and Methods
Primary B Cell Isolation and Culture. Spleens were isolated from 8-to 10-week-old p50
and C57BL͞6J WT control mice or from 129͞SvPasIcoCrlBR WT mice, which served as controls for spleens isolated from c-Rel Ϫ/Ϫ and p52 Ϫ/Ϫ mice. To obtain highly pure naïve B cells, total splenocytes were stained with a biotin-conjugated anti-CD43 Ab (Pharmingen) followed by streptavidin-conjugated magnetic microbeads (Miltenyi Biotec, Auburn, CA) and passed through a depletion-type magnetic sorting column (Miltenyi Biotec). Unbound cells were collected as the purified resting B cell sample: Ͼ96% pure B220 ϩ B cells expressing low levels of activation markers such as intercellular adhesion molecule 1, CD23, and B7.2 by fluorescence-activated cell sorter analysis (data not shown). B cells were cultured in RPMI medium 1640 supplemented with 10% FBS, 50 M 2-mercaptoethanol, and 1% penicillin͞streptomycin (Life Technologies, Rockville, MD) at 37°C under 10% CO 2 . Cells were stimulated (unless indicated otherwise) with 15 g͞ml anti-CD40 mAb, FgK-45, 5 g͞ml LPS, or 100 ng͞ml human B cell activation factor (hBAFF) (Amgen Biologicals). and 5Ј-TCACTTCCGACTGAAGAGTG (reverse); and UNG, 5Ј-GGGAAGCCGTACTTCGTCAA (forward) and 5Ј-GAT-GGGCTTCTTGCCAGACTT (reverse). For Q-PCR analysis, 1 g of RNA was reverse-transcribed by using SuperScript II (Invitrogen) according to the manufacturer's instructions with oligo(dT) and random hexamers serving as primers. Q-PCR analysis was done with the iCycler Thermocycler and Optical System (Bio-Rad) as described in ref. 20 . The primers listed here were used to amplify a specific 85-to 100-bp fragment of the following genes: c-Myc, 5ЈCTGCGACGAGAAGAGAGAATTTC (forward) and 5Ј-ACGCTGAATTTCTTCCAGATATCC (reverse); cyclin D2, 5Ј-CCGCCAGGAGCAAATCGAA (forward) and 5Ј-GACTTG-GATCCGGCGTTATG (reverse).
Immunoblotting. Whole-cell lysate and cell fractionation and nuclear Western blotting were done as described in ref. 19 . B cells were lysed in radioimmunoprecipitation assay buffer or fractionation buffer, and protein was quantified by using the BCA Protein Quantification Kit (Pierce). Thirty micrograms of protein was added to each lane and separated by either 9% or 12% SDS͞PAGE. Abs specific for murine Bcl-x L , p65, p52, and upstream stimulatory factor 2 were obtained from Santa Cruz Biotechnology. Anti-actin Ab and nonspecific rabbit IgG were purchased from Sigma. Gels were transferred to nitrocellulose membranes and immunoblotted according to the Ab manufacturer's recommended instructions.
Flow Cytometry of Intracellular Proteins. For intracellular staining of Bcl-x L , B cells were fixed and permeabilized by using the CytoFix͞Perm Kit (Pharmingen). In short, 5E5 cells were fixed and permeabilized in 0.25 ml of kit buffer overnight at 4°C. Cells were washed twice and stained with 10 g͞ml anti-Bcl-x L (Santa Cruz Biotechnology) or rabbit IgG (Sigma) and 1% normal mouse serum for 1 h on ice. After washing, cells were then stained with 5 g͞ml phycoerythrin anti-rabbit IgG for 1 h. Cells were fixed in 1% paraformaldehyde and analyzed by flow cytometry by using a FACScan with CELLQUEST software (Becton Dickinson).
Results

LPS and BAFF Preferentially Activate Type 1 or Type 2 NF-B Pathways, Respectively, Whereas CD40L Strongly Activates both in Primary B
Cells. CD40, like BAFF and LPS, can rescue primary B lymphocytes from in vitro spontaneous apoptosis and, like LPS, can also induce B cell proliferation and Ig isotype switching. In addition, CD40 has its unique functions in B cell activation such as homotypic aggregation and germinal center formation, which are not shared by either LPS or BAFF. To understand the contribution of both type 1 and type 2 NF-B pathways in CD40-mediated common (shared by BAFF and LPS) and unique events in B cell activation, we first compared the capacity of CD40, BAFF receptor (BAFF-R), and Toll-like receptor (TLR) 4 (receptor for LPS) to induce these two pathways in the context of primary murine splenic B cells.
First, B cells harvested from WT mice were cultured for 24 h in medium alone or in the presence of 15 g͞ml of an agonistic anti-CD40 mAb, 100 ng͞ml hBAFF, or 5 g͞ml LPS (these concentrations were used for all subsequent stimulations unless otherwise stated). Whole-cell lysate was collected, and the processing of p100 to p52 was assessed by Western blot analysis as an indication of the activation of the type 2 pathway. Anti-CD40 and hBAFF treatment, but not LPS treatment, of B cells resulted in the processing of p100 to p52 (Fig. 1A) . To better understand the kinetics of type 1 and type 2 NF-B activation by these stimuli, WT B cells were cultured in the presence of anti-CD40 mAb, hBAFF, or LPS for 4, 12, and 24 h. Nuclei were harvested and lysed for detection of p65 (a type 1 indicator) and p52 (from type 2 activation) nuclear translocation by Western blot. Results showed that only CD40 ligation led to sustained nuclear translocation of both p65 and p52, providing a possible explanation for the unique set of biological activities associated with CD40 in comparison with BAFF-R and TLR4 (Fig. 1B) .
CD40-Stimulated B Cells Retain Significant Survival After Either Single or Compound Loss of Rel Family Members. B cells from WT, p50
Ϫ/Ϫ , c-Rel Ϫ/Ϫ , and p52 Ϫ/Ϫ mice were stimulated in medium alone or with anti-CD40 mAb, hBAFF, or LPS for 48 h. Ligand-induced survival is reported as the percentage of specific viability (see Fig. 2 ) to adjust for differences across the various genotypes for unstimulated cells to remain viable. Whereas CD40-ligated B cells showed a minor reduction in cell survival in each Rel knockout background, hBAFF-and LPS-treated B cells displayed significant reduction in viability in this context. Specifically, the loss of p50 or c-Rel, but not p52, greatly reduced LPS-mediated survival, whereas the loss of p50 or p52, but not c-Rel, greatly reduced the rescue signal provided by hBAFF ( Fig.  2 A Upper) . Previous work has shown that compound Rel deficiency, specifically dual loss of p50 and c-Rel, completely abrogates LPS-mediated survival of primary B cells (21) . To examine whether the same were true for CD40-and hBAFFmediated survival, WT, p50 Ϫ/Ϫ c-Rel incapable of providing a rescue signal in the compound Reldeficient backgrounds. CD40 and BAFF-R ligation, on the other hand, retained approximately half of their WT survival signal in these same backgrounds ( Fig. 2 A Lower) .
To better understand the capacity of CD40 ligation to elicit significant survival in a compound Rel-deficient background, we compared the ability of anti-CD40 mAb, hBAFF, and LPS treatment to regulate the induction of Bcl-x L in WT and p50 Ϫ/Ϫ c-Rel
LPS was used to analyze Bcl-x L mRNA and protein by Northern and Western blot, respectively. As shown in Fig. 2B Left, anti-CD40 and LPS treatment, but not hBAFF treatment, of B cells led to significant induction of Bcl-x L mRNA. Interestingly, anti-CD40 treatment was able to maintain Bcl-x L induction much longer than LPS. In accordance with the Northern blot result, Western blot analysis demonstrated the ability of anti-CD40 and LPS treatment, but not hBAFF treatment, of B cells to induce significant Bcl-x L protein (Fig. 2B Right) . In addition, CD40 ligation led to higher levels of Bcl-x L protein than did LPS treatment, likely because of sustained Bcl-x L mRNA levels mediated by CD40. Next, WT and p50
B cells were stimulated with anti-CD40 mAb or LPS for 24 h. Intracellular staining of Bcl-x L protein showed that anti-CD40 and LPS treatment of WT B cells led to a significant increase in Bcl-x L protein in agreement with Western blot results (Fig. 2C  Left) . Simultaneous loss of p50, c-Rel, and one allele of p65, however, completely blocked LPS induction of Bcl-x L protein whereas CD40-mediated induction, although significantly diminished, was clearly measurable, thus providing some explanation for the capacity of CD40 to elicit significant rescue from apoptosis in the context of compound Rel deficiency. Previous studies have shown type 1 NF-B activity to be crucial for LPS-and anti-IgM-induced cell cycle entry of primary murine B cells (14, 22) . However, the ability of CD40 to activate both type 1 and type 2 NF-B activity, unlike LPS or anti-IgM, may render CD40-mediated cell cycle entry less sensitive (as seen in CD40-mediated survival) to deficiency in type 1 Rel family members. To examine this possibility, RNA from WT B cells cultured in the presence of anti-CD40 mAb, hBAFF, or LPS was isolated for Northern blot analysis of the G 1 -S transition genes c-Myc, CDK4, and cyclin D2. As expected, anti-CD40 and LPS treatment, but not hBAFF treatment, led to marked induc- (Fig. 3C Upper) , CD40-mediated cell cycle entry was blocked in the context of compound type 1 Rel deficiency, as published for LPS and anti-IgM (Fig. 3C Lower) .
CD40-Mediated Homotypic Aggregation of B Cells Requires Type 1 and
Type 2 NF-B Pathways. CD40 ligation on primary B cells is known to induce striking and highly stable homotypic aggregates by 24 h of culture (23, 24) . To examine the contribution of both type 1 and type 2 NF-B pathways in CD40-mediated homotypic aggregation, WT, p50 Ϫ/Ϫ , c-Rel (Fig. 5A) . To determine the contribution of type 1 and type 2 NF-B pathway activation to induction of these genes, RNA was isolated from WT, p50 Ϫ/Ϫ , c-Rel
, and p52 Ϫ/Ϫ B cells stimulated with anti-CD40 mAb and analyzed by Northern blot (Fig. 5B) . As predicted, genes activated by CD40 and TLR4 ligation and not BAFF-R, namely AID and UNG, required type 1 and not type 2 NF-B activity. Specifically, loss of p50 or c-Rel prevented CD40-mediated induction of AID, whereas loss of c-Rel, but not p50 or p52, delayed and reduced CD40-mediated induction of UNG. Furthermore, CD40-mediated induction of LEF-1 required p52, whereas loss of p50 actually enhanced induced mRNA levels. Interestingly, the CD40-specific target, Entactin, was found to require both type 1 and type 2 NF-B pathways because loss of p50, c-Rel, or p52 markedly reduced induced message levels.
Discussion
Primary B cells can be activated by means of a diverse set of surface receptors, including mediators of both innate and adaptive immunity. Upon ligation, such receptors, including CD40, BCR, TLR4, and TLR9, activate similar biochemical pathways, making it difficult to explain the mechanism of divergence in their respective gene expression profiles and induced cellular responses. However, studies on the mechanism of combinatorial control of gene regulation have revealed that variation in biochemical pathway activation results in marked differences in gene activation potential.
Previous work in our laboratory used high-density oligonucleotide arrays to compare the gene expression profiles of CD40L and LPS treatment of primary murine B cells (17) . Although these stimuli share the ability to activate the c-Jun N-terminal kinase͞stress-activated protein kinase, p38, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase͞mitogen-activated protein kinase pathways, in addition to type 1 NF-B activity, we identified gene activation unique to each ligand. Subsequent work revealed the capacity of LPS to specifically activate the transcription factor IFN regulatory factor 3 (32), which, together with NF-B, mediated the induction of a large set of the LPS-specific genes identified in our previous microarray study (20) . In this work, we explored the contribution of type 1 and type 2 NF-B pathways to B cell activation, and we provide evidence of type 2 NF-B activity as a possible explanation for unique CD40-mediated gene activation and cellular responses.
Primary B cells rapidly undergo spontaneous apoptosis in culture even in the presence of serum. Although treatment with CD40L, BAFF, and LPS can all rescue B cells from apoptosis, we found that they had differential requirements for individual NF-B subunits (see Fig. 2 A Upper) . In addition, whereas compound deficiency in type 1 Rel members completely blocked LPS-mediated survival, CD40 ligation retained a significant survival signal in this context (see Fig. 2 A Lower). Intracellular staining of Bcl-x L verified the capacity of CD40 ligation to induce a survival factor in p50 Ϫ/Ϫ c-Rel
B cells (see Fig. 2C ). Although we cannot exclude the contribution of other survival pathways, the remaining NF-B activity, especially the ability of CD40 ligation to activate both type 1 and type 2 NF-B pathways, is most likely involved in CD40-mediated survival of these cells, because the total NF-B inhibitors, Gliotoxin (20S and 26S proteasome inhibitor) and SN50 (a cell-permeable peptide that binds the Rel nuclear localization sequence), completely blocked CD40-mediated survival (data not shown). In support of this, we found that loss of p52 had an even greater affect than loss of p50 (33) on the ability of hBAFF to provide a rescue signal to B cells, implying that p52 can replace a significant portion of CD40-mediated survival lost in the absence of multiple type 1 Rel family members.
In contrast to cell survival, CD40-mediated induction of genes involved in cell proliferation (c-Myc, CDK4, or cyclin D2) and Ig isotype switching (AID and UNG) seems to depend mostly on type 1 but not type 2 NF-B activity. This is consistent with the observation that CD40L and LPS but not BAFF can strongly promote resting B lymphocytes for cell cycle entry and proliferation. Our gene expression studies are also consistent with previous functional studies indicating that deficiency in either p50 or c-Rel prevents Ig isotype switching elicited by multiple stimuli (13, 34) .
In addition to common functions such as proliferation and survival, CD40 ligation of primary B cells induces cellular responses not shared by either LPS or hBAFF. Our analysis of type 1 and type 2 NF-B contribution supports a model by which CD40L, LPS, and hBAFF common outcomes result from the shared capacity to activate either type 1 or type 2 NF-B, whereas the unique functions of CD40 result from the capacity to activate both pathways (Fig. 6) . Indeed, examination of CD40-mediated homotypic aggregation revealed that both pathways are required, because loss of c-Rel or p52 greatly reduced the formation of stable aggregates (see Fig. 4 ). In addition, Northern blot analysis of type 1 and type 2 NF-B contribution to CD40-mediated induction of Entactin and LEF-1 (two genes induced by CD40L but not LPS by microarray analysis) revealed that LEF-1 required the presence of p52 whereas Entactin required both type 1 and type 2 NF-B activity. Further studies are required to examine the mechanism of cooperative type 1 and type 2 NF-B activity to unique CD40-mediated B cell responses. Although CD40 ligation of B cells leads to the immediate and sustained activation of the type 1 pathway, strong activation of the type 2 pathway, for poorly understood reasons, requires substantial time. It is still not clear whether unique CD40-mediated B cell responses require specific periods of type 1 and type 2 NF-B synergy. To this point, it is worth noting that combinatorial treatment of WT B cells with LPS and hBAFF, which results in the activation of both type 1 and type 2 NF-B (data not shown), did not induce homotypic aggregates after 24 h of stimulation (data not shown). Interestingly, this combinatorial treatment did result in the formation of spherical clusters after 72 h of stimulation, although not to the extent of CD40 ligation (B.Z. and G.C., unpublished observations).
Thus, our studies reveal that the CD40-mediated gene expression and biological program require dual activation of the type 1 and type 2 NF-B pathways. Of course, CD40-mediated responses in B cells require the activation of additional biochemical pathways [e.g., p38 and extracellular signal-regulated kinase kinase pathways (17) ]. Continued investigation is required to understand how these signaling circuits cooperate in CD40 signal transduction and cellular responses. Our results are a reminder that the mechanisms by which cells execute diverse functions rely on the ability of different combinations of distinct but mostly shared stimuli to elicit divergent cellular responses. This phenomenon is no better exemplified than in CD40-mediated, T cell-dependent immune responses in which activated B cells, over many days, must integrate dozens of changing signals to achieve complex ends, including memory and plasma B cell differentiation. Fig. 6 . A model for the contribution of type 1 and type 2 NF-B in LPS-, CD40L-, and BAFF-induced B cell activation. CD40L activation of primary B cells shares common cellular outcomes with both LPS-and BAFF-mediated activation. In each case, these shared functions result from the shared capacity of these ligands to activate either type 1 or type 2 NF-B activity. In addition, CD40L's ability to activate both type 1 and type 2 NF-B activity results in unique, CD40-specific B cell responses.
